发明名称 TREATMENT OF HEPATITIS B INFECTION WITH THYMOSIN ALPHA 1 AND LAMIVUDINE
摘要 <p>A method of treatment of hepatitis B virus (HBV) infection in a patient by administering to the patient a drug regimen including an antiviral-effective amount of thymosin alpha 1 (Talpha1), an antiviral-effective amount of lamivudine, and optionally an antiviral-effective amount of famciclovir is disclosed.</p>
申请公布号 EP1115420(B1) 申请公布日期 2002.07.10
申请号 EP19990969679 申请日期 1999.09.22
申请人 SCICLONE PHARMACEUTICALS, INC. 发明人 LEUNG, YING-KIT
分类号 A61K31/513;A61K31/522;A61K38/22;A61P31/20;(IPC1-7):A61K38/22 主分类号 A61K31/513
代理机构 代理人
主权项
地址